Belite Bio Inc. - ADRBLTE
13F holders, Q4 2024 (December 31)22holders +7
8new positions
2sold out
1famous investor
$63.10avg. 13F price*
At the end of Q4 2024, 22 institutions reported holding Belite Bio Inc. - ADR (BLTE) in their 13F filings, up 7 from Q3 2024. 8 opened new positions and 2 sold out. The largest holders were Armistice Capital, LLC ($10.6M), State Street Corp. ($1.3M) and Bank of America Corp. ($1.2M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Belite Bio Inc. - ADR
- CUSIP
- 07782B104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $11.2M |
| Exits | 2 | $320K |
All 13F filers, Q3 2024 → Q4 2024: 215,178 shares bought and 11,480 shares sold, net +203,698 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Armistice Capital, LLC | 0.25% | New | 167,930 | $10.6M |
| State Street Corp. | 0.00% | Reduce -0.3% | 20,017 | $1.3M |
| Bank of America Corp. | 0.00% | Add +36.4% | 18,342 | $1.2M |
| JPMorgan Chase & Co. | 0.00% | Add +130.3% | 14,636 | $924K |
| UBS Group AG | 0.00% | Add +9436.7% | 12,207 | $770K |
| Morgan Stanley | 0.00% | Add +1503.9% | 10,618 | $670K |
| XTX Topco Ltd | 0.04% | Add +30.9% | 7,062 | $446K |
| Geode Capital Management, LLC | 0.00% | No change | 6,700 | $423K |
| Goldman Sachs Group Inc. | 0.00% | New | 6,326 | $399K |
| Marshall Wace, LLP | 0.00% | Reduce -30.9% | 5,865 | $370K |
| Citadel Advisors | 0.00% | Reduce -19.3% | 5,211 | $329K |
| BNP Paribas Financial Markets | 0.00% | New | 2,450 | $155K |
| Rhumbline Advisers | 0.00% | No change | 1,435 | $91K |
| GAMMA Investing LLC | 0.01% | Add +48.1% | 1,290 | $81K |
| Virtus Advisers, LLC | 0.03% | Reduce -39.1% | 1,122 | $71K |
| Advisors Preferred, LLC | 0.01% | New | 798 | $52K |
| Mirae Asset Global Investments Co., Ltd. | 0.00% | New | 357 | $22K |
| SBI Securities Co., Ltd. | 0.00% | — | 14 | $883 |
| Quantbot Technologies LP | 0.00% | New | 11 | $694 |
| PNC Financial Services Group, Inc. | 0.00% | New | 8 | $505 |
| Osaic Holdings, Inc. | 0.00% | Reduce -12.5% | 7 | $442 |
| Royal Bank of Canada | 0.00% | New | 5 | $0 |
"% of holder's portfolio" is BLTE's weight in each manager's 13F, not the share of Belite Bio Inc. - ADR the manager owns.